1. Occurrence of pulmonary embolism related to COVID-19
- Author
-
Marie Hauguel-Moreau, Céline Bégué, Quentin De Baynast, Nicolas Mansencal, Hazrije Mustafic, Guillaume Geri, Robert Carlier, Mostafa El Hajjam, Anne-Sophie Lot, Olivier Dubourg, Antoine Vieillard-Baron, Sébastien Beaune, Thierry Chinet, Service de cardiologie et maladies vasculaires [CHU Ambroise Paré], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Ambroise Paré [AP-HP], Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Handicap neuromusculaire : Physiopathologie, Biothérapie et Pharmacologies appliquées (END-ICAP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Ambroise Paré [AP-HP], Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie (BECCOH), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay, Optimisation thérapeutique en Neuropsychopharmacologie (OPTeN (UMR_S_1144 / U1144)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), and HAL UVSQ, Équipe
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,Coronavirus disease 2019 (COVID-19) ,030204 cardiovascular system & hematology ,Risk Assessment ,Gastroenterology ,Article ,03 medical and health sciences ,Patient Admission ,0302 clinical medicine ,[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,Risk Factors ,Internal medicine ,White blood cell ,Heart rate ,medicine ,Humans ,Hospital Mortality ,030212 general & internal medicine ,Aged ,Aged, 80 and over ,business.industry ,Incidence ,Incidence (epidemiology) ,Pulmonary embolism ,COVID-19 ,Thrombosis ,Hematology ,Wbc count ,Middle Aged ,Prognosis ,medicine.disease ,[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,3. Good health ,Increased risk ,medicine.anatomical_structure ,Female ,France ,Cardiology and Cardiovascular Medicine ,business ,Cohort study - Abstract
Recent reports have suggested an increased risk of pulmonary embolism (PE) related to COVID-19. The aim of this cohort study is to compare the incidence of PE during a 3-year period and to assess the characteristics of PE in COVID-19. We studied consecutive patients presenting with PE (January 2017–April 2020). Clinical presentation, computed tomography (CT) and biological markers were systematically assessed. We recorded the global number of hospitalizations during the COVID-19 pandemic and during the same period in 2018-2019. We included 347 patients: 326 without COVID-19 and 21 with COVID-19. Patients with COVID-19 experienced more likely dyspnea (p=0.04), had lower arterial oxygen saturation (p
- Published
- 2020
- Full Text
- View/download PDF